Pozen, AstraZeneca file suit against Dr. Reddy’s over generic Vimovo
CHAPEL HILL, N.C. — A generic drug maker is being sued for patent infringement for its version of a fixed-dose combination drug co-created by Pozen and AstraZeneca.
Pozen and AstraZeneca on Monday said that they have filed the suit in the U.S. District Court for the District of New Jersey against Dr. Reddy’s. The drug makers said Dr. Reddy’s is seeking approval from the Food and Drug Administration for its generic version of Vimovo (naproxen/esomeprazole magnesium) delayed-release tablets prior to the patent’s expiration date. Vimovo currently has regulatory exclusivity through April 30, 2013, Pozen and AstraZeneca said.
The filing of this patent infringement lawsuit by AstraZeneca and Pozen within 45 days of receipt of Dr. Reddy’s notice letter will result in the FDA automatically instituting a stay or bar of final approval of Dr. Reddy’s abbreviated new drug application for up to 30 months, or until a final court decision is entered in the infringement suit in favor of Dr. Reddy’s, whichever occurs first.
Fruth reforms small-town Rx
Regional player Fruth Pharmacy is re- energizing its business. “We are entering our 59th year of business and trying to continue to provide that small-town, quality customer service while staying competitive and on the cutting edge with all of the programs that are out there on the pharmacy side,” said Lynne Fruth, chairman and newly appointed Fruth president.
Fruth started a campaign in February whereby patients write in to share why they value their pharmacist, and their comments are featured in print ads and online. So far, the company has received as many as 500 responses.
With regard to pharmacy services, the company is improving medication adherence among patients, offering medication therapy management via a shared faculty arrangement with West Virginia University, helping patients make lifestyle changes and successfully improve their health via a cardiovascular wellness program, and making a transition from a nursing- and clinic-driven immunization program to an “immunize anytime” concept that likely will feature expanded offerings, explained Craig Kimble, director of pharmacy.
Lewis overhaul plays up Rx
Lewis Drug has a new face, which not only places a greater emphasis on the front end, but also boasts a larger, revamped pharmacy.
Those who have visited the newly opened store on Louise Avenue in Sioux Falls, S.D., undoubtedly will see the Lewis Drug store of the future, president and CEO Mark Griffin told Drug Store News in a recent interview.
The pharmacy area is about one-third larger than a typical Lewis Drug pharmacy and has been revamped. “Call it the new face of Lewis Drug. It incorporates an upscale environment, the beauty boutique, plank flooring in the pharmacy and an entertainment area in the pharmacy for waiting with flat-screen TVs and refreshments,” Griffin said. This new store also includes a “four seasons department,” which is a 4,000-sq.-ft. environmentally controlled room that can be used for various purposes throughout the year.
In addition, Lewis Drug has expanded its grocery departments in about a dozen locations. In its larger stores, about 2,000 sq. ft. to 3,000 sq. ft. have been dedicated to grocery items with a concentration on snack foods, grab-and-go items and frozen foods.